Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Achieve Life Sciences News

    4,63 $ +1,98% +0,09 $
    In : 4,3162 € | 19:37:43 Uhr Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A2QAR3
    ISIN: US0044685008
    US-Symbol: ACHV
    Typ: Aktie

    Achieve Life Sciences News

    12.12.23 - PR Newswire
    Thinking about buying stock in Advanced Micro Devices, Palo Alto Networks, Gaotu Techedu, Achieve Life Sciences, or Clearmind Medicine?
    Thinking about buying stock in Advanced Micro Devices, Palo Alto Networks, Gaotu Techedu, Achieve Life Sciences, or Clearmind Medicine? PR Newswire
    16.05.22 - ACCESSWIRE
    36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022
    RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16 th - 20 th , 2022, where 36 SmallCap, ...
    27.04.22 - PR Newswire
    Thinking about buying stock in Agile Therapeutics, Constellium SE, Achieve Life Sciences, Alliance Resource Partners, or Nordic American Tanker?
    Thinking about buying stock in Agile Therapeutics, Constellium SE, Achieve Life Sciences, Alliance Resource Partners, or Nordic American Tanker? PR Newswire
    28.01.22 - ACCESSWIRE
    36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022
    RALEIGH, NC / ACCESSWIRE / January 28, 2022 / The Winter Wonderland Best Ideas Virtual Investor Conference will take place on February 8 th - 11 th , 2022, where 36 SmallCap, ...
    15.09.21 - ACCESSWIRE
    Achieve Life Sciences to Participate in Upcoming Investor Conferences
    SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / September 15, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-​stage pharmaceutical company committed to the ...
    14.09.21 - ACCESSWIRE
    Achieve Life Sciences Announces Presentation of Cytisinicline Data at the 21st Annual Society for Research on Nicotine & Tobacco (SRNT-E) Virtual Conference
    SEATTLE, WA & VANCOUVER, BC / ACCESSWIRE / September 14, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-​stage pharmaceutical company committed to the ...
    13.08.21 - ACCESSWIRE
    Achieve Life Sciences Announces Expansion of Cytisinicline Clinical Operations Team and Granting of Inducement Awards
    SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / August 13, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-​stage pharmaceutical company committed to the ...
    11.08.21 - ACCESSWIRE
    Achieve Reports Financial Results for Second Quarter 2021 and Provides Corporate Update
    SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / August 12, 2021 / Achieve Life Sciences, Inc. (Nasdaq:ACHV), a clinical-​stage pharmaceutical company committed to the ...
    11.08.21 - ACCESSWIRE
    Achieve Announces Two Patents Granted by USPTO for Novel Cytisinicline Dosing and Administration Regimen
    SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / August 11, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-​stage pharmaceutical company committed to the ...
    03.08.21 - ACCESSWIRE
    Achieve Life Sciences to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 12, 2021
    SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / August 3, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-​stage pharmaceutical company committed to the ...
    22.07.21 - ACCESSWIRE
    Achieve Life Sciences Awarded Grant from the National Institutes of Health (NIH) for the Evaluation of Cytisinicline in Cessation of Nicotine E-cigarette Use
    SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / July 22, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-​stage pharmaceutical company committed to the global ...
    29.06.21 - ACCESSWIRE
    Achieve Announces Completion of Target Enrollment of 750 Subjects in Phase 3 ORCA-2 Smoking Cessation Trial of Cytisinicline
    ORCA-2 Designed to Assess the Efficacy and Safety of 3 mg Cytisinicline Three Times Daily Dosing Compared to Placebo in Adult Smokers in the United States
    03.06.21 - ACCESSWIRE
    Achieve Announces Allowance of U.S. Patents for Dosing and Administration of Cytisinicline for the Treatment and Prevention of Addiction
    SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / June 3, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-​stage pharmaceutical company committed to the global ...
    02.06.21 - ACCESSWIRE
    Achieve Life Sciences to Present at LD Micro Invitational XI Virtual Conference
    SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / June 2, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-​stage pharmaceutical company committed to the global ...
    27.05.21 - ACCESSWIRE
    Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
    SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / May 27, 2021 / Achieve Life Sciences, Inc. (Nasdaq:ACHV), a clinical-​stage pharmaceutical company committed to the global ...
    25.05.21 - ACCESSWIRE
    Achieve Life Sciences Announces Pricing of $20 Million Underwritten Public Offering
    SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / May 25, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-​stage pharmaceutical company committed to the global ...
    24.05.21 - ACCESSWIRE
    Achieve Life Sciences Announces Proposed Underwritten Public Offering
    SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / May 24, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-​stage pharmaceutical company committed to the global ...
    13.05.21 - ACCESSWIRE
    Achieve Reports Financial Results for First Quarter 2021 and Provides Corporate Update
    SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / May 13, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-​stage pharmaceutical company committed to the global ...
    04.05.21 - ACCESSWIRE
    Achieve Life Sciences to Announce First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 13, 2021
    SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / May 4, 2021 / Achieve Life Sciences, Inc. (Nasdaq:ACHV), a clinical-​stage pharmaceutical company committed to the global ...
    22.04.21 - ACCESSWIRE
    Achieve Life Sciences, Inc. to Host Virtual Non-Deal Roadshow on Tuesday, April 27, 2021
    SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / April 22, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-​stage pharmaceutical company committed to the global ...

    Newssuche

    Videos

    newspaper
    09:30 Uhr +26,02%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »